Fiserv faces a downgrade from Cantor Fitzgerald with a new price target of $53, down nearly 17% from its recent price of $63.80. The company cut its 2026 guidance, expecting flat to slightly negative organic growth and a 14.2% drop in earnings per share to $7.41. Profitability concerns are highlighted by a significant decline in operating margin from 39.6% to 31.8%. Despite generating $1.10 billion in free cash flow, the stock trades at a low multiple of 6.5 times expected earnings, reflecting market skepticism about its near-term prospects.
Scotiabank increased its price target for Palo Alto Networks to $430, suggesting a 13% upside from current levels, following a 30% surge in shares after strong Q3 results. The cybersecurity firm is expected to deliver robust Q4 performance and signif...
BioMarin Pharmaceutical Inc. saw its stock gain momentum after Jefferies raised its price target to $105, signaling strong confidence in the biotech firm. The company secured new revenue streams through a patent settlement with Ascendis Pharma, earni...
Aehr Test Systems' CEO sold shares worth $5.2 million following a remarkable 564% increase in the company's stock price. This significant sale highlights the CEO capitalizing on the stock's strong rally. Investors may view this move as a signal about...
Zoomd Technologies Ltd. reported a second-quarter EPS of $0.01, surpassing analyst estimates of $0.0038, signaling better-than-expected profitability. Although quarterly revenue was $7.67 million, slightly below the $8.41 million forecast, the compan...
Snowflake's stock surged following a price target increase to $405 by Cantor Fitzgerald analyst Thomas Blakey, signaling a 24.21% upside. Analysts expect strong Q2 results with earnings of $0.45 per share and revenues of $1.47 billion, reflecting nea...
